Figure 5
Probability of HBeAg seroconversion in 105 ETV-treated HBeAg-positive CHB patients in relation to decrease rate of IP-10 levels after 1 year of treatment (p < 0.001 by log-rank test).
Figure 5 | Scientific Reports
Probability of HBeAg seroconversion in 105 ETV-treated HBeAg-positive CHB patients in relation to decrease rate of IP-10 levels after 1 year of treatment (p < 0.001 by log-rank test).
